trending Market Intelligence /marketintelligence/en/news-insights/trending/wzDNaRbHle3P-at5vrP_KA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Bellicum appoints president, CEO

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Bellicum appoints president, CEO

Rick Fair was appointed Bellicum Pharmaceuticals Inc.'s president, CEO and member of the company's board.

Fair succeeds Tom Farrell who would serve as an adviser to the company during the transition. Fair was senior vice president and head of oncology global product strategy at Genentech, a Roche Holding Ltd. subsidiary.